Weight-loss treatments like semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) have been life changing for many individuals seeking to manage their weight. However, shortages and high ...

Health-care marketplace Sesame announced a new clinical weight loss program that will help eligible consumers access compounded versions of Novo Nordisk’s blockbuster obesity drug Wegovy for $249 per ...

We're living in the era of Ozempic. For others, however, the accessibility has led to misuse. "We have a little bit of a wild west in who's writing for this medication now, because it is so ...

In recent years, an increasing number of health care providers and patients have turned to compounded drugs for the treatment of hormone-related health concerns. These products are often marketed as ...